BVS Q3 2022 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$129M+18.2% YoY

Gross Profit

$85M65.7% margin

Operating Income

-$127M-98.6% margin

Net Income

-$108M-84.1% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-8.3%

Cash Flow

Operating Cash Flow

-$701,000

Free Cash Flow

-$2M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$1.0B

Stockholders' Equity

$343M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$109M	+18.2%
Gross Profit	$85M	$79M	+6.9%
Operating Income	-$127M	-$1M	-12014.5%
Net Income	-$108M	-$1M	-10006.9%

Geographic Segments

UNITED STATES

$31M91%

Non-US

$3M9%